A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Cognition disorders; Down syndrome
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 14 Mar 2017 New trial record